Effects of bone cement particles on the function of pseudocapsule-derived fibroblasts

Acta Orthopaedica

Volumn 77, Issue 2, 2006, Pages 320-328

  Si, Guo Sun ^a   Bao, An Ma ^a   Zhou, Yong ^a   Ming, Hua Zhang ^a   Qing, Yu Fan ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BONE CEMENT; CYTOKINE; INTERLEUKIN 6; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; MALE; OSTEOCLAST; OSTEOLYSIS; PROSTHESIS LOOSENING; PROTEIN DETERMINATION; PROTEIN SECRETION; STEM CELL; TISSUE CULTURE;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; BONE CEMENTS; BONE RESORPTION; CARRIER PROTEINS; CYTOKINES; FEMALE; FIBROBLASTS; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; PARTICLE SIZE; POLYMETHYL METHACRYLATE; PROSTHESIS FAILURE; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TISSUE CULTURE TECHNIQUES;

EID: 33645777482     PISSN: 17453674     EISSN: 17453682     Source Type: Journal    
DOI: 10.1080/17453670610046091     Document Type: Article

References (23)

1. Abbas S, Clohisy J C, Abu-Amer Y. Mitogen-activated protein (MAP) kinases mediate PMMA-induction of osteoclasts. J Orthop Res 2003; 21 (6): 1041-8.
2. Baumann B, Rader C P, Seufert J, Noth U, Rolf O, Eulert J, Jakob F. Effects of polyethylene and TiAlV wear particles on expression of RANK, RANKL and OPG mRNA. Acta Orthop Scand 2004; 75 (3): 295-302.
3. Blair H C, Athanasou N A. Recent advances in osteoclast biology and pathological bone resorption. Histol Histopathol 2004; 19(1): 189-99.
4. Bukata S V, Gelinas J, Wei X, Rosier R N, Puzas J E, Zhang X, Schwarz E M, Song X Y, Griswold D E, O'Keefe R J. PGE2 and IL-6 production by fibroblasts in response to titanium wear debris particles is mediated through a Cox-2 dependent pathway. J Orthop Res 2004; 22 (1): 6-12.
5. Campbell P A, Wang M, Amstutz H C, Goodman S B. Positive cytokine production in failed metal-on-metal total hip replacements. Acta Orthop Scand 2002; 73 (5): 506-512.
6. Crotti T N, Smith M D, Findlay D M, Zreiqat H, Ahern M J, Weedon H, Hatzinikolous G, Capone M, Holding C, Haynes D R. Factors regulating osteoclast formation in human tissues adjacent to peri-implant bone loss: expression of receptor activator NFkappaB, RANK ligand and osteoprotegerin. Biomaterials 2004; 25 (4): 565-73.
7. Fuller K, Murphy C, Kirstein B, Fox S W, Chambers T J. TNFalpha potently activates osteoclasts, through a direct action independent of and strongly synergistic with RANKL. Endocrinology 2002; 143 (3): 1108-18.
8. Gallo J, Kaminek P, Ticha V, Rihakova P, Ditmar R. Particle disease. A comprehensive theory of periprosthetic osteolysis: a review. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2002; 146 (2): 21-8.
9. Green T R, Fisher J, Matthews J B, Stone M H, Ingham E. Effect of size and dose on bone resorption activity of macrophages by in vitro clinically relevant ultra high molecular weight polyethylene particles. J Biomed Mater Res 2000; 53 (5): 490-7.
10. Haynes D R, Crotti T N, Zreiqat H. Regulation of osteoclast activity in peri-implant tissues. Biomaterials 2004; 25 (20): 4877-85.
11. Horiki M, Nakase T, Myoui A, Sugano N, Nishii T, Tomita T, Miyaji T, Yoshikawa H. Localization of RANKL in osteolytic tissue around a loosened joint prosthesis. J Bone Miner Metab 2004; 22 (4): 346-51.
12. Kobayashi K, Takahashi N, Jimi E, Udagawa N, Takami M, Kotake S, Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Morinaga T, Higashio K, Martin T J, Suda T. Tumor necrosis factor alpha stimulates osteoclast differentiation by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp Med 2000; 191 (2): 275-86.
13. Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA. Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism. Bone 2003; 32 (1): 1-7.
14. Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y. IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 2004; 15(1): 49-60.
15. Liu X H, Kirschenbaum A, Yao S, Levine A C. Cross-talk between the IL-6 and prostaglandin E2 signaling systems results in enhancement of osteoclastgenesis through effects on the OPG/RANKL/RANK system. Endocrinology 2005; 146 (4): 1991-8.
16. Mabrey J D, Afsar-Keshmiri A, Engh G A, Sychterz C J, Wirth M A, Rockwood C A, Agrawal C M. Standardized analysis of UHMWPE wear particles from failed total joint arthroplasties. J Biomed Mater Res 2002; 63 (5): 475-83.
17. Mandelin J, Liljestrom M, Li T F, Ainola M, Hukkanen M, Salo J, Santavirta S, Konttinen Y T. Pseudosynovial fluid from loosened total hip prosthesis induces osteoclast formation J Biomed Mater Res B Appl Biomater 2005a; 74 (1): 582-8.
18. Mandelin J, Li T F, Hukkanen M, Liljestrom M, Salo J, Santavirta S, Konttinen Y T. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K J Rheumatol 2005b; 32 (4): 713-20.
19. Palmqvist P, Persson E, Conaway H H, Lerner U H. IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol 2002; 169 (6): 3353-62.
20. Quinn J M, Horwood N J, Elliott J, Gillespie M T, Martin T J. Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation. J Bone Miner Res 2000; 15 (8): 1459-66.
21. Sabokbar A, Pandey R, Athanasou N A. The effect of particle size and electrical charge on macrophage-osteoclast differentiation and bone resorption. J Mater Sci Mater Med 2003; 14 (9): 731-8.
22. Sakai H, Jingushi S, Shuto T, Urabe K, Ikenoue T, Okazaki K, Kukita T, Kukita A. Fibroblasts from the inner granulation tissue of the pseudocapsule in hips at revision arthroplasty induce osteoclast differentiation, as do stromal cells. Ann Rheum Dis 2002; 61 (2): 103-9.
23. Skoglund B, Aspenberg P. PMMA particles and pressure - a study of the osteolytic properties of two agents proposed to cause prosthetic loosening. J Orthop Res 2003; 21 (2): 196-201.